A detailed history of Correct Capital Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Correct Capital Wealth Management holds 6,074 shares of ABBV stock, worth $1.07 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
6,074
Previous 5,411 12.25%
Holding current value
$1.07 Million
Previous $985,000 5.69%
% of portfolio
0.32%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $102,625 - $119,843
663 Added 12.25%
6,074 $1.04 Million
Q1 2024

Aug 13, 2024

BUY
$159.82 - $182.1 $108,997 - $124,192
682 Added 14.42%
5,411 $985,000
Q4 2023

Aug 13, 2024

BUY
$137.6 - $154.97 $650,710 - $732,853
4,729 New
4,729 $732,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Correct Capital Wealth Management Portfolio

Follow Correct Capital Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Correct Capital Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Correct Capital Wealth Management with notifications on news.